Citi downgrades Hims & Hers to Sell on valuation concerns
Citi downgraded Hims & Hers to Sell from Neutral with a price target of $25, up from $24. The firm thinks the market is overvaluing the ...
Don't Buy Hims & Hers Stock If You Want Better Than Mediocre Returns
What initially stands out to me about Hims & Hers is the company's distinct branding and feel of luxury, which is evident on ...
Hims & Hers Health, Inc. (NYSE:HIMS) Given Consensus Recommendation of “Hold” by Brokerages
Shares of Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) have been given a consensus recommendation of “Hold” by the ...
Hims & Hers downgraded to Sell from Neutral at Citi
Citi downgraded Hims & Hers to Sell from Neutral with a $25 price target Stay Ahead of the Market:Discover outperforming stocks and invest ...
What's Going On With Hims & Hers Health Stock?
Hims & Hers reported impressive third-quarter results in November, with earnings of 32 cents per share, far exceeding analyst expectations.
Hims & Hers: Ready For Liftoff In 2025
Hims & Hers' robust Q3 2024 performance, driven by a 44% increase in subscribers and 77% y/y revenue growth, underscores its ...
Is Hims & Hers Health a Millionaire Maker?
John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors.
What 12 Analyst Ratings Have To Say About Hims & Hers Health
Ratings for Hims & Hers Health HIMS were provided by 12 analysts in the past three months, showcasing a mix of bullish and ...
Hims & Hers Health (NYSE:HIMS) Price Target Raised to $24.00 at Piper Sandler
Hims & Hers Health (NYSE:HIMS – Free Report) had its target price lifted by Piper Sandler from $21.00 to $24.00 in a report ...
Hims and Hers Health put volume heavy and directionally bearish
Bearish flow noted in Hims and Hers Health with 25,948 puts trading, or 1.4x expected. Most active are Mar-25 27 puts and Jan-25 26 puts, with ...